GlassScriptPhysician profile
Timothy S Howard
NPI 1366700932
$4,988.57
in general payments reported to CMS, 2019-2025
23 companies · $239 in 2025
The $239 reported for 2025 was less than what a typical Pain Medicine provider received nationally (typical 2025 total: $515).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $3,194 · 2020: $224 · 2021: $387 · 2022: $260 · 2023: $341 · 2024: $344 · 2025: $239.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $924.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $923.54 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Vertiflex, INC. | $1,744.25 | 2019 | |
| Vertos Medical, INC. | $1,255.82 | 2019-2023 | Mild Device Kit |
| Medtronic, INC. | $286.18 | 2021-2025 | Kyphon Express II Kyphopak Tray |
| Nevro Corp. | $257.80 | 2024 | Senza |
| Abbott Laboratories | $251.26 | 2019-2025 | Eterna, Proclaim |
| Si-Bone, INC. | $229.69 | 2019-2025 | |
| Medtronic USA, INC. | $223.72 | 2019-2020 | |
| Boston Scientific Corporation | $191.94 | 2020-2023 | |
| Ferring Pharmaceuticals INC. | $144.30 | 2019-2022 | |
| Endo Pharmaceuticals INC. | $77.17 | 2019-2024 | Xiaflex |
| Amgen INC. | $45.07 | 2019-2021 | |
| Bioventus LLC | $43.62 | 2019-2022 | |
| Allergan, INC. | $42.09 | 2020 | |
| Endo USA, INC. | $37.43 | 2024 | Xiaflex |
| Biotronik Nro, INC. | $26.87 | 2025 | Prospera |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pacira Therapeutics, INC. | $24.16 | 2021 | |
| Fidia Pharma USA INC. | $21.62 | 2023 | Hymovis, Triluron |
| Assertio Therapeutics, INC. | $18.71 | 2019 | |
| Spinal Simplicity, LLC | $15.24 | 2024 | Ha Minuteman G3-R |
| Siemens Medical Solutions USA, INC. | $14.14 | 2020 | |
| Biodelivery Sciences International, INC. | $13.73 | 2021 | |
| Adamas Pharmaceuticals, INC. | $12.39 | 2019 | |
| Teva Pharmaceuticals USA, INC. | $11.37 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Timothy Howard listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.